13F HOLDINGS REPORT (Amended)
Samsara BioCapital, LLC
Quarter ended Q1 2023 · Filed February 15, 2023 · Accession 0001104659-23-022435
Total Value
$3.2M
Positions
1
Other Managers
0
Confidential Omitted
No
Holdings (1)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SYROS PHARMACEUTICALS INC | 87184Q206 | 881,450 | $3.2M | 100.00% |